{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:10:20Z","timestamp":1779289820173,"version":"3.51.4"},"reference-count":6,"publisher":"Europa Digital & Publishing","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EuroIntervention"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.4244\/eijy14m08_11","type":"journal-article","created":{"date-parts":[[2015,4,13]],"date-time":"2015-04-13T13:04:26Z","timestamp":1428930266000},"page":"1276-1279","source":"Crossref","is-referenced-by-count":15,"title":["Safety of second-generation drug-eluting stents three years after randomised use in the TWENTE trial"],"prefix":"10.4244","volume":"10","author":[{"given":"Marije M.","family":"L\u00f6wik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming Kai","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanim","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Tandjung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Gert","family":"van Houwelingen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frits H.A.F.","family":"de Man","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin G.","family":"Stoel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. (Hans) W.","family":"Louwerenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard C.M.","family":"Linssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine J.M.","family":"Doggen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"von Birgelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2774","reference":[{"key":"key-201538144344-0","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.jacc.2013.12.036","article-title":"Four year clinical outcomes and predictors of repeat revascularization in patients treated with new generation drug-eluting stents in the RESOLUTE All Comers Randomized Trial.","volume":"63","author":"Taniwaki M.","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"key-201538144344-1","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.jacc.2012.01.008","article-title":"A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial.","volume":"59","author":"von Birgelen C.","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"key-201538144344-2","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1016\/j.jacc.2013.04.005","article-title":"Clinical outcome following stringent discontinuation of dual antiplatelet therapy after 12 months in real-world patients treated with second-generation zotarolimus-eluting resolute and everolimus-eluting Xience V stents: 2-year follow-up of the randomized TWENTE trial.","volume":"61","author":"Tandjung K.","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"key-201538144344-3","doi-asserted-by":"publisher","first-page":"664","DOI":"10.4244\/EIJV8I6A104","article-title":"Comparison of eligible non-enrolled patients and the randomised TWENTE trial population treated with Resolute and Xience V drug-eluting stents.","volume":"8","author":"Sen H.","year":"2012","journal-title":"EuroIntervention."},{"key":"key-201538144344-4","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions.","volume":"115","author":"Cutlip DE.","year":"2007","journal-title":"Circulation."},{"key":"key-201538144344-5","doi-asserted-by":"publisher","first-page":"871","DOI":"10.4244\/EIJV5I7A146","article-title":"Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies.","volume":"5","author":"Vranckx P.","year":"2010","journal-title":"EuroIntervention."}],"container-title":["EuroIntervention"],"original-title":[],"deposited":{"date-parts":[[2015,4,13]],"date-time":"2015-04-13T13:04:52Z","timestamp":1428930292000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.pcronline.com\/eurointervention\/82nd_issue\/215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":6,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["20140228-01"],"URL":"https:\/\/doi.org\/10.4244\/eijy14m08_11","relation":{},"ISSN":["1774-024X"],"issn-type":[{"value":"1774-024X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}